ViCentra

Utrecht, The Netherlands

ViCentra has developed an insulin pump for diabetes patients.

$13.0M raised

Jan 2026

Series D

Top Investors

Invest-NLEQT Life SciencesInnovation IndustriesInkefKreos Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ViCentra raised?

ViCentra has raised $13.0M in total funding. The most recent round was Series D. The last funding was announced in January 2026.

Who are ViCentra's investors?

ViCentra's investors include Invest-NL, EQT Life Sciences, Innovation Industries, Inkef, Kreos Capital.

Where is ViCentra headquartered?

ViCentra is headquartered in Utrecht, The Netherlands.

What does ViCentra do?

ViCentra has developed an insulin pump for diabetes patients.

What stage is ViCentra at?

ViCentra is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 8, 2026.

MLA

"ViCentra — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/vicentra. Accessed June 3, 2026.

APA

VCBacked. (2026). ViCentra — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/vicentra

Wikipedia (cite web)

{{cite web |title=ViCentra — Funding & Investors |url=https://www.vcbacked.co/company/vicentra |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 8, 2026.